Zevra Therapeutics (ZVRA) Stock Rises Sharply After Key Regulatory Decision
Following a pivotal regulatory endorsement, Zevra Therapeutics, Inc. (NASDAQ: ZVRA) stock experienced a notable increase on the US charts, which led ZVRA shares to rose 15.87%, closing at $7.30. What FDA Committee has Endorsed? Zevra (ZVRA) stated that the Genetic Metabolic Diseases Advisory Committee (GeMDAC) of the U.S. Food and Drug Administration (FDA) voted 11 […]
